scispace - formally typeset
Search or ask a question
Journal ArticleDOI

Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.

TL;DR: The data show that MDPV is a monoamine transporter blocker with increased potency and selectivity for catecholamines when compared with cocaine, and may provide a mechanism to explain the adverse effects observed in humans taking high doses of ‘bath salts’ preparations.
About: This article is published in Neuropsychopharmacology.The article was published on 2013-03-01 and is currently open access. It has received 375 citations till now. The article focuses on the topics: Bath salts & Methylenedioxypyrovalerone.
Citations
More filters
Journal ArticleDOI
TL;DR: Insight is provided into the development of synthetic cathinones as substances of abuse, current patterns of their abuse, known mechanisms of their action and toxicology, and the benefits and drawbacks of their classification.

313 citations


Cites background from "Powerful cocaine-like actions of 3,..."

  • ...…when applied to synaptosomes, not only block DAT and SERT uptake (Baumann et al., 2012a, Martinez-Clemente et al., 2012) but act as DAT and SERT substrates, releasing neurotransmitter from synaptosomes (Baumann, Ayestas, 2012a, Baumann et al., 2012b, Cameron et al., 2012, Hadlock, Webb, 2011)....

    [...]

  • ...In vitro transporter assays further confirm that mephedrone and methylone, when applied to synaptosomes, not only block DAT and SERT uptake (Baumann et al., 2012a, Martinez-Clemente et al., 2012) but act as DAT and SERT substrates, releasing neurotransmitter from synaptosomes (Baumann, Ayestas,…...

    [...]

Journal ArticleDOI
TL;DR: The present work provides a review on khat and synthetic cathinones, concerning their historical background, prevalence, patterns of use, legal status, chemistry, pharmacokinetics, pharmacodynamics, and their physiological and toxicological effects on animals and humans.
Abstract: For centuries, 'khat sessions' have played a key role in the social and cultural traditions among several communities around Saudi Arabia and most East African countries. The identification of cathinone as the main psychoactive compound of khat leaves, exhibiting amphetamine-like pharmacological properties, resulted in the synthesis of several derivatives structurally similar to this so-called natural amphetamine. Synthetic cathinones were primarily developed for therapeutic purposes, but promptly started being misused and extensively abused for their euphoric effects. In the mid-2000's, synthetic cathinones emerged in the recreational drug markets as legal alternatives ('legal highs') to amphetamine, 'ecstasy', or cocaine. Currently, they are sold as 'bath salts' or 'plant food', under ambiguous labels lacking information about their true contents. Cathinone derivatives are conveniently available online or at 'smartshops' and are much more affordable than the traditional illicit drugs. Despite the scarcity of scientific data on these 'legal highs', synthetic cathinones use became an increasingly popular practice worldwide. Additionally, criminalization of these derivatives is often useless since for each specific substance that gets legally controlled, one or more structurally modified analogs are introduced into the legal market. Chemically, these substances are structurally related to amphetamine. For this reason, cathinone derivatives share with this drug both central nervous system stimulating and sympathomimetic features. Reports of intoxication and deaths related to the use of 'bath salts' have been frequently described over the last years, and several attempts to apply a legislative control on synthetic cathinones have been made. However, further research on their pharmacological and toxicological properties is fully required in order to access the actual potential harm of synthetic cathinones to general public health. The present work provides a review on khat and synthetic cathinones, concerning their historical background, prevalence, patterns of use, legal status, chemistry, pharmacokinetics, pharmacodynamics, and their physiological and toxicological effects on animals and humans.

278 citations


Cites background from "Powerful cocaine-like actions of 3,..."

  • ...Despite the scarcity of experimental data on the pharmacological and toxicological properties of these ‘legal highs’, based on the structural similarities of cathinone derivatives with other amphetamines like MDMA (3,4-methylenedioxymethamphetamine, ‘ecstasy’), identical effects are predictable....

    [...]

  • ...MDPv acts as a pure monoamine-selective transporter blocker, with high potency for DAT and NeT (50-fold and 10-fold more potent than cocaine, respectively), but weak for SeRT (10- fold less potent than cocaine) (Baumann et al. 2013b; cameron et al. 2013)....

    [...]

  • ...Phase II metabolic pathways may include reactions of acetylation, glucuronidation or sulfonation of the hydroxyl groups, with the resultant metabolites being excreted in the urine. like amphetamine, MeTH, and MDMA, synthetic cathinones exert their effects by interacting with catecholamine transporters (DAT, NeT, and SeRT), which results in increased synaptic concentrations of these monoamines....

    [...]

  • ...Nonetheless, MePH was shown to potentiate the neurotoxicity evoked by other illicit drugs, such as MeTH, amphetamine, and MDMA (Angoa-Pérez et al. 2013)....

    [...]

  • ...On one hand, MePH is capable of inducing MDMA- and cocainelike subjective effects, which may contribute to its indiscriminate abuse (carhart-Harris et al. 2011; Deluca et al. 2009b)....

    [...]

Journal ArticleDOI
TL;DR: A credible transport model must account for monoaminergic neurons' distinct mode of action and link this to subtle differences in activity and undesired, potentially deleterious effects.

217 citations


Cites background from "Powerful cocaine-like actions of 3,..."

  • ...potentiates release, while a blocker is inactive (for an example see the characterization of MDPV in [84]....

    [...]

Journal ArticleDOI
TL;DR: The major clinical effects of synthetic cathinones are reviewed to highlight their impact on public health.
Abstract: New psychoactive substances (NPS) have completely modified the drug scene and the current landscape of addiction. Synthetic substances, such as substituted or synthetic cathinones, also known as « legal highs », are often produced and used to mimic the effects of controlled drugs such as cocaine, methylenedioxymethamphetamine (MDMA, ecstasy), and methamphetamine. The overwhelming majority of synthetic cathinones are produced in China and South East Asian countries. The Internet has emerged as the new marketplace for NPS, playing a major role in providing information on acquisition, synthesis, extraction, identification, and substance use. All these compounds are intentionally mislabeled and sold on-line under slang terms such as bath salts, plant food, plant feeders and research chemicals. They are sometimes labeled « not for human use » or « not tested for hazards or toxicity ». The rapid spread of NPS forces member countries of the European Union to adapt their response to the potential new dangers that may cause. To date, not only health actors but also the general public need to be clearly informed and aware of dangers resulting from NPS spread and use. Here, we review the major clinical effects of synthetic cathinones to highlight their impact on public health. A literature search was conducted from 2009 to 2014 based on PubMed, Google Scholar, Erowid, and governmental websites, using the following keywords alone or in combination: "new psychoactive substances", "synthetic cathinones", "substituted cathinones", "mephedrone", "methylone", "MDPV", "4-MEC", "addiction", and "substance use disorder".

202 citations


Cites background from "Powerful cocaine-like actions of 3,..."

  • ...MDPV is at least 10 times more potent than cocaine at producing locomotor activation and stereotypies [41], while mephedrone-induced effects on locomotor activity are similar to MDMA but lower than amphetamine [42]....

    [...]

  • ...MDPV-related psychoactive effects resembling those of cocaine, which lasts from 3 to 4 hours [41]....

    [...]

Journal ArticleDOI
TL;DR: Strengths of ICSS in comparison with drug self-administration include potential for simultaneous evaluation of both abuse-related and abuse-limiting effects, flexibility for use with various routes of drug administration or drug vehicles, utility for studies in drug-naive subjects as well as in subjects with controlled levels of prior drug exposure, and utility for Studies of drug time course.
Abstract: Intracranial self-stimulation (ICSS) is a behavioral procedure in which operant responding is maintained by pulses of electrical brain stimulation. In research to study abuse-related drug effects, ICSS relies on electrode placements that target the medial forebrain bundle at the level of the lateral hypothalamus, and experimental sessions manipulate frequency or amplitude of stimulation to engender a wide range of baseline response rates or response probabilities. Under these conditions, drug-induced increases in low rates/probabilities of responding maintained by low frequencies/amplitudes of stimulation are interpreted as an abuse-related effect. Conversely, drug-induced decreases in high rates/probabilities of responding maintained by high frequencies/amplitudes of stimulation can be interpreted as an abuse-limiting effect. Overall abuse potential can be inferred from the relative expression of abuse-related and abuse-limiting effects. The sensitivity and selectivity of ICSS to detect abuse potential of many classes of abused drugs is similar to the sensitivity and selectivity of drug self-administration procedures. Moreover, similar to progressive-ratio drug self-administration procedures, ICSS data can be used to rank the relative abuse potential of different drugs. Strengths of ICSS in comparison with drug self-administration include 1) potential for simultaneous evaluation of both abuse-related and abuse-limiting effects, 2) flexibility for use with various routes of drug administration or drug vehicles, 3) utility for studies in drug-naive subjects as well as in subjects with controlled levels of prior drug exposure, and 4) utility for studies of drug time course. Taken together, these considerations suggest that ICSS can make significant contributions to the practice of abuse potential testing.

188 citations


Cites background from "Powerful cocaine-like actions of 3,..."

  • ...Uptake inhibitors differ from releasers only in appearing to tolerate a greater proportion of 5HT effects than releasers (c.f. MDMA and cocaine are relatively nonselective compounds at DAT versus SERT, but cocaine produces more robust ICSS facilitation)....

    [...]

  • ...MK801 has not been approved for clinical use and has not been considered for scheduling by the FDA, but for the remaining three compounds, the hierarchy of abuse potential from ICSS studies corresponds roughly to the FDA scheduling hierarchy for these compounds, where PCP is schedule 1, ketamine is schedule 3, and memantine is unscheduled....

    [...]

  • ...Effects of repeated/ chronic treatment with monoamine uptake inhibitors have been evaluated with cocaine and with some SERT- and NET-selective uptake inhibitors that are used clinically as antidepressants....

    [...]

  • ...Methylenedioxypyrovalerone (MDPV) is a cathinone derivative that has recently emerged as a designer drug of abuse often included in “bath salts,” and it has been designated as a schedule 1 drug by the U.S. Food and Drug Administration (FDA) (Baumann et al., 2013b)....

    [...]

  • ...Of particular relevance to abuse potential testing, a family of novel monoamine releasers (and uptake inhibitors, see below) with street names such as “bath salts” has recently emerged as a new source of illicit drugs in Europe and North America (Baumann et al., 2013a; De Felice et al., 2014)....

    [...]

References
More filters
Journal ArticleDOI
01 Jan 2001-Synapse
TL;DR: In vitro methods determined the neurochemical mechanism of action of amphetamine, 3,4‐methylenedioxymethamphetamine (MDMA), (+)‐methamphetamine, ephedrine, phentermine, and aminorex, and demonstrated that the most potent effect of these stimulants is to release NE.
Abstract: A large body of evidence supports the hypothesis that mesolimbic dopamine (DA) mediates, in animal models, the reinforcing effects of central nervous system stimulants such as cocaine and amphetamine. The role DA plays in mediating amphetamine-type subjective effects of stimulants in humans remains to be established. Both amphetamine and cocaine increase norepinephrine (NE) via stimulation of release and inhibition of reuptake, respectively. If increases in NE mediate amphetamine-type subjective effects of stimulants in humans, then one would predict that stimulant medications that produce amphetamine-type subjective effects in humans should share the ability to increase NE. To test this hypothesis, we determined, using in vitro methods, the neurochemical mechanism of action of amphetamine, 3,4-methylenedioxymethamphetamine (MDMA), (+)-methamphetamine, ephedrine, phentermine, and aminorex. As expected, their rank order of potency for DA release was similar to their rank order of potency in published self-administration studies. Interestingly, the results demonstrated that the most potent effect of these stimulants is to release NE. Importantly, the oral dose of these stimulants, which produce amphetamine-type subjective effects in humans, correlated with the their potency in releasing NE, not DA, and did not decrease plasma prolactin, an effect mediated by DA release. These results suggest that NE may contribute to the amphetamine-type subjective effects of stimulants in humans.

884 citations


"Powerful cocaine-like actions of 3,..." refers background or methods in this paper

  • ...In Vitro Uptake and Release Assays in Synaptosomes Rats were euthanized by CO2 narcosis, and the brains were processed to yield synaptosomes as previously described (Rothman et al, 2001; Rothman et al, 2003b)....

    [...]

  • ...It is well established that traditional uptake inhibition assays cannot distinguish between drugs acting as transporter blockers vs those acting as substrates (ie, releasers; Rothman et al, 2001; Rothman et al, 2003b)....

    [...]

  • ...For example, we have shown that established uptake blockers like GBR12909 and indatraline display low-efficacy releasing effects in synaptosomes (Rothman and Baumann, 2003a; Rothman et al, 2001)....

    [...]

Journal ArticleDOI
TL;DR: This dissertation aims to provide a history of web exceptionalism from 1989 to 2002, a period chosen in order to explore its roots as well as specific cases up to and including the year in which descriptions of “Web 2.0” began to circulate.

810 citations


"Powerful cocaine-like actions of 3,..." refers background in this paper

  • ...It is well established that drug-induced elevations in extracellular dopamine in the nucleus accumbens are involved with locomotor-activating properties of stimulant drugs (Ikemoto, 2002; Pennartz et al, 1994)....

    [...]

Journal ArticleDOI
TL;DR: New insights are obtained into the molecular mechanisms whereby amphetamine, and the closely related compounds methamphetamine and methylenedioxymethamphetamine, cause monoamine, and particularly dopamine, release, which have potential implications for both amphetamine- and methamphetamine-induced neurotoxicity, as well as dopaminergic neurodegenerative diseases.
Abstract: Amphetamine is a psychostimulant commonly used to treat several disorders, including attention deficit, narcolepsy, and obesity. Plasmalemmal and vesicular monoamine transporters, such as the neuronal dopamine transporter and the vesicular monoamine transporter-2, are two of its principal targets. This review focuses on new insights, obtained from both in vivo and in vitro studies, into the molecular mechanisms whereby amphetamine, and the closely related compounds methamphetamine and methylenedioxymethamphetamine, cause monoamine, and particularly dopamine, release. These mechanisms include amphetamine-induced exchange diffusion, reverse transport, and channel-like transport phenomena as well as the weak base properties of amphetamine. Additionally, amphetamine analogs may affect monoamine transporters through phosphorylation, transporter trafficking, and the production of reactive oxygen and nitrogen species. All of these mechanisms have potential implications for both amphetamine- and methamphetamine-induced neurotoxicity, as well as dopaminergic neurodegenerative diseases.

680 citations


"Powerful cocaine-like actions of 3,..." refers background in this paper

  • ...…but not blockers, are known to produce long-term deficits in monoamine neurons that are often viewed as neurotoxicity (Baumann et al, 2007; Fleckenstein et al, 2007); and (3) Neuropsychopharmacology there are conflicting reports in the literature regarding the precise interactions of…...

    [...]

Journal ArticleDOI
TL;DR: Monensin, a monovalent ion-selective ionophore, has gained wide-spread acceptance as a tool for studying Golgi apparatus function and for localizing and identifying the molecular pathways of subcellular vesicular traffic involving acid compartments.

591 citations


"Powerful cocaine-like actions of 3,..." refers methods in this paper

  • ...In the superfusion experiments, cells are pretreated with the Naþ /Hþ ionophore monensin, which alters ionic gradients to increase cytoplasmic Naþ (Mollenhauer et al, 1990; Turetta et al, 2004)....

    [...]

Journal ArticleDOI
TL;DR: The emergence of a new group of substances of abuse in the USA, known as bath salts, is reported with quantitative results in 18 patients, the first report of MDPV exposures with quantitative blood level confirmation.
Abstract: Recently, there has been a worldwide rise in the popularity and abuse of synthetic cathinones. In 2009 and 2010, a significant rise in the abuse of a new group of synthetic cathinones was reported ...

499 citations


"Powerful cocaine-like actions of 3,..." refers background in this paper

  • ...All rights reserved 0893-133X/12 www.neuropsychopharmacology.org Holstege, 2012; Kyle et al, 2011; Murray et al, 2012; Spiller et al, 2011)....

    [...]

  • ...All three of the Schedule I cathinones, depicted in (Figure 1), have been identified in bath salts products (Ross et al, 2011; Spiller et al, 2011), but MDPV is the chief substance found in the blood and urine from patients exposed to bath salts who are admitted to emergency departments in the…...

    [...]

  • ...…(eg, caffeine) can be found in bath salts products, but MDPV is the main compound detected in biological fluids from patients admitted to emergency departments for bath salts overdose in the United States (Borek and Holstege, 2012; Kyle et al, 2011; Murray et al, 2012; Spiller et al, 2011)....

    [...]

  • ...In particular, synthetic analogs of the plantderived stimulant cathinone are being sold online and in retail shops as legal alternatives to illicit drugs like cocaine, amphetamine, and 3,4-methylenedioxymethamphetamine (MDMA; Ross et al, 2011; Spiller et al, 2011)....

    [...]

  • ...…to emergency departments for bath salts overdose, who have toxicological verification of MDPV consumption, display symptoms, including agitation, psychosis, violent behavior, hyperthermia, and tachycardia (Borek and Holstege, 2012; Kyle et al, 2011; Murray et al, 2012; Spiller et al, 2011)....

    [...]